RNA-dependent activation of primer RNA production by influenza virus polymerase: different regions of the same protein subunit constitute the two required RNA-binding sites.
The capped RNA primers required for the initiation of influenza virus mRNA synthesis are produced by the viral polymerase itself, which consists of three proteins PB1, PB2 and PA. Production of primers is activated only when the 5'- and 3'-terminal sequences of virion RNA (vRNA) bind sequentially to the polymerase, indicating that vRNA molecules function not only as templates for mRNA synthesis but also as essential cofactors which activate catalytic functions. Using thio U-substituted RNA and UV crosslinking, we demonstrate that the 5' and 3' sequences of vRNA bind to different amino acid sequences in the same protein subunit, the PB1 protein. Mutagenesis experiments proved that these two amino acid sequences constitute the functional RNA-binding sites. The 5' sequence of vRNA binds to an amino acid sequence centered around two arginine residues at positions 571 and 572, causing an allosteric alteration which activates two new functions of the polymerase complex. In addition to the PB2 protein subunit acquiring the ability to bind 5'-capped ends of RNAs, the PB1 protein itself acquires the ability to bind the 3' sequence of vRNA, via a ribonucleoprotein 1 (RNP1)-like motif, amino acids 249-256, which contains two phenylalanine residues required for binding. Binding to this site induces a second allosteric alteration which results in the activation of the endonuclease that produces the capped RNA primers needed for mRNA synthesis. Hence, the PB1 protein plays a central role in the catalytic activity of the viral polymerase, not only in the catalysis of RNA-chain elongation but also in the activation of the enzyme activities that produce capped RNA primers.
Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, NJ 08855, USA.
M L
ML
Li
B C
BC
Ramirez
R M
RM
Krug
D001120:Arginine / Q000378:metabolism; D001665:Binding Sites; D012321:DNA-Directed RNA Polymerases / Q000378:metabolism*; D009975:Orthomyxoviridae / Q000201:enzymology*; D010649:Phenylalanine / Q000378:metabolism; D011485:Protein Binding; D012313:RNA / Q000378:metabolism; D012315:RNA Caps; D012367:RNA, Viral / Q000378:metabolism*; D016601:RNA-Binding Proteins / Q000378:metabolism*; D012324:RNA-Dependent RNA Polymerase; D014764:Viral Proteins / Q000378:metabolism*
C057027:PB2 protein, Influenzavirus A; D012315:RNA Caps; C034477:RNA primers; D012367:RNA, Viral; D016601:RNA-Binding Proteins; D014764:Viral Proteins; C077346:influenza virus polymerase basic protein 1; D010649:Phenylalanine; D012313:RNA; D001120:Arginine; D012324:RNA-Dependent RNA Polymerase; D012321:DNA-Directed RNA Polymerases